Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice.
about
Interferon-γ links ultraviolet radiation to melanomagenesis in miceBroad-Spectrum Drugs Against Viral AgentsCationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements.Immunostimulatory and anti-neoplasm effects of a novel palindrome CpG oligodeoxynucleotide in mice.Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in miceComparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites.Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections.Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection.CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infectionA protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection.A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei.Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infectionCD40 is required for protective immunity against liver stage Plasmodium infectionLocal delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccineCpG DNA: trigger of sepsis, mediator of protection, or both?CpG-ODN Class C Mediated Immunostimulation in Rabbit Model of Trypanosoma evansi InfectionThe Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice.CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes.Use of CpG oligodeoxynucleotides as immunoprotective agents.Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice.Filarial infection suppresses malaria-specific multifunctional Th1 and Th17 responses in malaria and filarial coinfectionsTweaking Innate Immunity: the Promise of Innate Immunologicals As Anti-infectivesLimiting inflammatory responses during activation of innate immunity.Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different familiesImmune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.Antiinfective applications of toll-like receptor 9 agonists.Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malariaPlatelet factor 4 limits Th17 differentiation and cardiac allograft rejection.NK Cells: Uncertain Allies against Malaria.Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status.Photodynamic therapy-generated tumor cell lysates with CpG-oligodeoxynucleotide enhance immunotherapy efficacy in human papillomavirus 16 (E6/E7) immortalized tumor cells.Intraperitoneal prophylaxis with CpG oligodeoxynucleotides protects neutropenic mice against intracerebral Escherichia coli K1 infection.CpG oligodeoxynucleotides inhibit tumor growth and reverse the immunosuppression caused by the therapy with 5-fluorouracil in murine hepatoma.Contribution of nitric oxide to CpG-mediated protection against Listeria monocytogenes.The effect of CpG-ODN on antigen presenting cells of the foal.
P2860
Q24631120-9DC2C2A5-56EB-43FA-A6B1-0BD795BB07F5Q27487859-9E2BBDF9-C6DB-4D42-88E9-11869834965CQ33367582-6A191B58-067C-4AB3-9377-929C1FF9095CQ33571317-49D46C9B-E81C-4038-BA17-BED3E18D033AQ33587443-A2BCE6AB-9A09-4C7E-A89A-CD00FD30C643Q33980715-C199B473-BDAA-4EAC-8824-2AD28B844D08Q33996076-4F4575C6-D348-4E59-8EB9-A4108D48AC7AQ33997771-F2E96B70-D603-4CD5-9A4E-C7E6585DBADEQ34064539-10EDFA51-838D-44E7-9DEF-A1FF42EBE3AEQ34118325-46A166D3-ACF9-43F1-BC54-31B3DB20901AQ34145320-0020EA28-F8B8-4E03-848F-35DB44388B80Q34402230-3DD0963B-C63B-40D1-B412-22BE45178AFFQ34465399-38E80924-24D7-46F8-A4DD-A3C4CA5D04F5Q34491754-C550E050-48C6-4975-9278-D12479912DD1Q34941937-223A7AF7-4752-4F36-A59A-D3C8A09CB6BFQ35122368-C91D4578-59D7-4CA0-A805-68517D19F44BQ35182216-77190CE0-EEF0-45CD-8DFB-2B1BA78209BFQ35550770-35603848-741A-46D3-9A36-CC4D52F08FE1Q35585084-00F76BFF-706F-4C28-A789-9818A8E5D9EAQ35651568-78A2141E-C7AD-4456-B507-881A5E3F7E52Q35757996-973FC536-EDE9-4F57-A92C-DAFA2C777841Q35784051-C846DF7B-C4FE-456B-9CA7-B0F5DE70576DQ35790879-9A0F77F7-645B-4099-82A6-744577B6D479Q35801755-22C21CD9-40B3-46D1-BDAF-2F7320AE02AEQ36125714-A297CF5C-9004-4755-B45E-1B253D9EAAC6Q36171257-D6276B50-53C8-4824-9B4E-BA64A2416B68Q36348742-553C3617-5EB0-4E6E-9490-F247CB09E91CQ36445263-05856D04-8D94-4AB1-B0FA-046692443BFCQ36510121-F1208971-8699-481C-B55F-7CCC30CE8809Q36526351-96C89FE5-2B54-43F6-B750-866DB20B7322Q36868322-C32F91CE-49CB-466F-83F2-F4757AE579B9Q37146236-65695DCC-03BF-4F4F-B6C6-F015841D25F1Q37524290-07DAB48C-FFEE-4B42-AF54-B51354B3A396Q37689434-02D3DCCB-358E-4050-AB6D-F7B86E97B1AEQ39910093-4C0EABB7-F039-46C0-B578-BC0CCC8ED58FQ40147269-9B6CD7A8-8C84-4A56-B1B6-53FF0DF6E48FQ41900201-130AD975-ABE0-4BEB-B0B7-CB703A8DE170Q42142467-810B01B8-CD85-46C7-B2BA-8DFE7BB15D36Q42151564-A7DD332A-37D2-4232-ABC3-D6181D370131Q42957702-578C9ADF-1660-4A0C-B166-02F4B8F07C15
P2860
Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Interleukin-12- and gamma inte ...... oligodeoxynucleotide in mice.
@ast
Interleukin-12- and gamma inte ...... oligodeoxynucleotide in mice.
@en
Interleukin-12- and gamma inte ...... oligodeoxynucleotide in mice.
@nl
type
label
Interleukin-12- and gamma inte ...... oligodeoxynucleotide in mice.
@ast
Interleukin-12- and gamma inte ...... oligodeoxynucleotide in mice.
@en
Interleukin-12- and gamma inte ...... oligodeoxynucleotide in mice.
@nl
prefLabel
Interleukin-12- and gamma inte ...... oligodeoxynucleotide in mice.
@ast
Interleukin-12- and gamma inte ...... oligodeoxynucleotide in mice.
@en
Interleukin-12- and gamma inte ...... oligodeoxynucleotide in mice.
@nl
P2093
P2860
P1476
Interleukin-12- and gamma inte ...... oligodeoxynucleotide in mice.
@en
P2093
D L Doolan
R A Gramzinski
S L Hoffman
P2860
P304
P356
10.1128/IAI.69.3.1643-1649.2001
P407
P577
2001-03-01T00:00:00Z